Related posts
3 Cannabis Stocks to go HigherThursday markets recover early lossesStocks rally on easing Russian tensionsThis summary was created by AI, based on 7 opinions in the last 12 months.
Experts have mixed opinions about Constellation Brands Inc (STZ-N). While some are concerned about the impact of a diabetes drug on liquor sales and the current weakness in the spirits industry, others are optimistic about the company's strong beer sales and its growth in Mexican beer sales. There is also a belief that the company is undervalued despite facing roadblocks like a bad investment in cannabis-maker Canopy Growth and the founders selling shares.
Spirits sales have been weak in the industry the past year, so he greeted STZ's earning today with worry. Beer sales did very well, but not wine and spirits. Still, STZ raised its full-year earnings and cash flow forecast. Shares were up 2% today after an early sell-off.
Unlike liquor sales, beer sales are healthy. STZ's Mexican beer sales are growing. Their most quarter boasted 12% net sales growth (i.e. Corona, Modelo).
Largest beer important company in USA. Shares up 30% in past 5 years. Lots of upside potential. Modest dividend yield. Management appear to be prioritizing revenue growth. Would prefer companies like Walmart. If heading into recession, would be good for defensive investors.
So-called experts are now urging you to buy this stock, but STZ is already up 17% YTD, having been a huge beneficiary of the problems with Bud Light. Don't be a victim of these momentum chasers. In fact, take some profits now.
Don't average down. He has little faith in Canopy, but believes in Constellation who delivered a great quarter, but nobody cared. This will change.
He's long owned this, but the stock has hit several road blocks including a bad investment in cannabis-maker Canopy Growth and the company founders selling huge amounts of shares. he's stuck with it, because he believes in their Mexican beers like Modelo. They just reported solid numbers, like an earnings beat, and a sunny forecast about beer sales even wine/spirits isn't doing as well. Is a long way from last year's highs, but is undervalued.
Constellation Brands Inc is a American stock, trading under the symbol STZ-N on the New York Stock Exchange (STZ). It is usually referred to as NYSE:STZ or STZ-N
In the last year, 6 stock analysts published opinions about STZ-N. 4 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Constellation Brands Inc.
Constellation Brands Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Constellation Brands Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
6 stock analysts on Stockchase covered Constellation Brands Inc In the last year. It is a trending stock that is worth watching.
On 2024-03-28, Constellation Brands Inc (STZ-N) stock closed at a price of $271.76.
The drug impacts hard liquor, not beer. Doesn't know why. He's watching this.